Literature DB >> 20155265

Moving from lymph node metastasis in gastric cancer to biological markers: reply to letter.

Naoto Fukuda.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20155265     DOI： 10.1007/s00268-010-0461-0

Source DB:  PubMed          Journal:  World J Surg        ISSN： 0364-2313            Impact factor:   3.352


× No keyword cloud information.
  11 in total

1.  The superiority of ratio-based lymph node staging in gastric carcinoma.

Authors:  Kentaro Inoue; Yasushi Nakane; Hitoshi Iiyama; Mutsuya Sato; Tatsuya Kanbara; Koji Nakai; Syunichiro Okumura; Keigo Yamamichi; Koshiro Hioki
Journal:  Ann Surg Oncol       Date:  2002 Jan-Feb       Impact factor: 5.344

2.  Ratio of metastatic lymph nodes: impact on staging and survival of gastric cancer.

Authors:  R Persiani; S Rausei; A Biondi; S Boccia; F Cananzi; D D'Ugo
Journal:  Eur J Surg Oncol       Date:  2007-07-10       Impact factor: 4.424

3.  Metastatic/resected lymph nodes ratio-based classification in gastric cancer.

Authors:  Halil Ozgüç; Yalçin Sönmez; Omer Yerci
Journal:  Turk J Gastroenterol       Date:  2008-03       Impact factor: 1.852

4.  Outcome of ratio of lymph node metastasis in gastric carcinoma.

Authors:  Etsuro Bando; Yutaka Yonemura; Keizo Taniguchi; Sachio Fushida; Takashi Fujimura; Koichi Miwa
Journal:  Ann Surg Oncol       Date:  2002-10       Impact factor: 5.344

5.  A feasibility study of sequential paclitaxel and S-1 (PTX/S-1) chemotherapy as postoperative adjuvant chemotherapy for advanced gastric cancer.

Authors:  Michiya Kobayashi; Akira Tsuburaya; Naoki Nagata; Yumi Miyashita; Koji Oba; Junichi Sakamoto
Journal:  Gastric Cancer       Date:  2006       Impact factor: 7.370

6.  Ratio between metastatic and examined lymph nodes is an independent prognostic factor after D2 resection for gastric cancer: analysis of a large European monoinstitutional experience.

Authors:  Donato Nitti; Alberto Marchet; Matteo Olivieri; Alessandro Ambrosi; Roberto Mencarelli; Claudio Belluco; Mario Lise
Journal:  Ann Surg Oncol       Date:  2003-11       Impact factor: 5.344

7.  Prognostic significance of the ratio between metastatic and dissected lymph nodes (n ratio) in patients with advanced gastric cancer.

Authors:  Hiroaki Saito; Yoji Fukumoto; Tomohiro Osaki; Yoshinori Yamada; Kenji Fukuda; Shigeru Tatebe; Shunichi Tsujitani; Masahide Ikeguchi
Journal:  J Surg Oncol       Date:  2008-02-01       Impact factor: 3.454

8.  Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine.

Authors:  Shinichi Sakuramoto; Mitsuru Sasako; Toshiharu Yamaguchi; Taira Kinoshita; Masashi Fujii; Atsushi Nashimoto; Hiroshi Furukawa; Toshifusa Nakajima; Yasuo Ohashi; Hiroshi Imamura; Masayuki Higashino; Yoshitaka Yamamura; Akira Kurita; Kuniyoshi Arai
Journal:  N Engl J Med       Date:  2007-11-01       Impact factor: 91.245

9.  Phase II study of biweekly docetaxel and S-1 combination therapy for advanced or recurrent gastric cancer.

Authors:  Yoshihiro Kakeji; Eiji Oki; Akinori Egashira; Noriaki Sadanaga; Ikuo Takahashi; Masaru Morita; Yasunori Emi; Yoshihiko Maehara
Journal:  Oncology       Date:  2009-06-25       Impact factor: 2.935

10.  Targeting gastric cancer with trastuzumab: new clinical practice and innovative developments to overcome resistance.

Authors:  Dimitrios H Roukos
Journal:  Ann Surg Oncol       Date:  2009-10-20       Impact factor: 5.344
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.